AAAAAA

   
Results: 1-9 |
Results: 9
TRANSFECTION OF GPIIB(ILE176) IIIA (FRANKFURT-I) IN MAMMALIAN-CELLS/
Authors: WESTRUP D SANTOSO S BECKERHAGENDORFF K JUST M JABLONKA B SEIFRIED E KIRCHMAIER CM
Citation: D. Westrup et al., TRANSFECTION OF GPIIB(ILE176) IIIA (FRANKFURT-I) IN MAMMALIAN-CELLS/, Thrombosis and haemostasis, 1997, pp. 2740-2740
INHIBITION OF FIBRINOGEN BINDING TO GLYCOPROTEIN IIB IIIA AS A NOVEL BIOASSAY FOR THE DETERMINATION OF FIBRINOGEN RECEPTOR ANTAGONISTIC PLASMA EQUIVALENTS/
Authors: JABLONKA B BROCKMEIER D JUST M MAAS J SCHMIDT D SEIBERTGRAFE M STILZ U
Citation: B. Jablonka et al., INHIBITION OF FIBRINOGEN BINDING TO GLYCOPROTEIN IIB IIIA AS A NOVEL BIOASSAY FOR THE DETERMINATION OF FIBRINOGEN RECEPTOR ANTAGONISTIC PLASMA EQUIVALENTS/, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 17-17
A NEW VARIANT OF GLANZMANNS-THROMBASTHENIA WITH DEFECTIVE ACTIVATION-DEPENDENT FIBRINOGEN BINDING AND ALTERED EXPRESSION OF EPITOPES FOR SEVERAL MONOCLONAL-ANTIBODIES AGAINST GP IIB-IIIA
Authors: MEYER M THIEME A JABLONKA B JUST M STROHL C SCHELLENBERG I KIRCHMAIER CM
Citation: M. Meyer et al., A NEW VARIANT OF GLANZMANNS-THROMBASTHENIA WITH DEFECTIVE ACTIVATION-DEPENDENT FIBRINOGEN BINDING AND ALTERED EXPRESSION OF EPITOPES FOR SEVERAL MONOCLONAL-ANTIBODIES AGAINST GP IIB-IIIA, Platelets, 7(4), 1996, pp. 215-224
FROM PEPTIDES TO HETEROCYCLIC PEPTIDE MIMETICS - DESIGN AND SYNTHESISOF AN ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST FOR THE PREVENTIONOF THROMBOSIS
Authors: STILZ HU BECK G JABLONKA B JUST M
Citation: Hu. Stilz et al., FROM PEPTIDES TO HETEROCYCLIC PEPTIDE MIMETICS - DESIGN AND SYNTHESISOF AN ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST FOR THE PREVENTIONOF THROMBOSIS, Bulletin des Societes chimiques belges, 105(10-11), 1996, pp. 711-719
DISCOVERY OF AN ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST
Authors: STILZ HU JABLONKA B JUST M KNOLLE J PAULUS EF ZOLLER G
Citation: Hu. Stilz et al., DISCOVERY OF AN ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 39(11), 1996, pp. 2118-2122
A NEW VARIANT OF GLANZMANNS-THROMBASTHENIA (FRANKFURT-I)
Authors: KIRCHMAIER CM WESTRUP D BECKERHAGENDORFF K JUST M JABLONKA B SEIFRIED E
Citation: Cm. Kirchmaier et al., A NEW VARIANT OF GLANZMANNS-THROMBASTHENIA (FRANKFURT-I), Thrombosis and haemostasis, 73(6), 1995, pp. 1058-1058
BIOLOGICAL CHARACTERISTICS OF THE NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST - S-1762
Authors: JUST M HROPOT M JABLONKA B KONIG W STILZ HU
Citation: M. Just et al., BIOLOGICAL CHARACTERISTICS OF THE NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST - S-1762, Thrombosis and haemostasis, 73(6), 1995, pp. 1444-1444
PHOSPHORYLATION OF FOCAL ADHESION VASODILATOR-STIMULATED PHOSPHOPROTEIN AT SER157 IN INTACT HUMAN PLATELETS CORRELATES WITH FIBRINOGEN RECEPTOR INHIBITION
Authors: HORSTRUP K JABLONKA B HONIGLIEDL P JUST M KOCHSIEK K WALTER U
Citation: K. Horstrup et al., PHOSPHORYLATION OF FOCAL ADHESION VASODILATOR-STIMULATED PHOSPHOPROTEIN AT SER157 IN INTACT HUMAN PLATELETS CORRELATES WITH FIBRINOGEN RECEPTOR INHIBITION, European journal of biochemistry, 225(1), 1994, pp. 21-27
PREDICTION OF BLEEDING RISK IN GLANZMANN THROMBASTHENIA
Authors: KIRCHMAIER CM SCHIRMER A JABLONKA B MEYER M JUST M BREDDIN HK
Citation: Cm. Kirchmaier et al., PREDICTION OF BLEEDING RISK IN GLANZMANN THROMBASTHENIA, Thrombosis and haemostasis, 69(6), 1993, pp. 921-921
Risultati: 1-9 |